Cardinal Health expands Actinium-225 production capacity to support growing demand for novel cancer therapies

B DUBLIN, Ohio, April 1, 2026 /PRNewswire/ — Cardinal Health (NYSE:CAH) today announced a significant expansion of its Actinium-225 (Ac-225) production capabilities at the company’s…

posteditor
posteditor
Articles: 27298

Other News